Web Results


Nov 24, 2017 ... Recipients of fax advertisements from Impax Laboratories may qualify for payments under the terms of a $4.8 million junk fax class action settlement. ... If you're unsure if you qualify, please read the FAQ section of the Settlement Administrator's website to ensure you meet all standards (Top Class Actions is ...


Mar 29, 2018 ... Impax Laboratories Inc. on Thursday reached a $20 million midtrial settlement with a class of consumers and insurers, ending a suit in Massachusetts federal ... The case is In re: Solodyn (Minocycline Hydrochloride) Antitrust Litigation, case number 1:14-md-02503, in the U.S. District Court for the District of ...


Apr 5, 2018 ... A Massachusetts federal judge gave her initial approval Thursday to Impax Laboratories Inc.'s $20 million midtrial settlement with a class of consumers and insurers that claimed the lab delayed the launch of a generic acne medicine in exchange for a $40 million payment.


Mar 12, 2018 ... Impax Laboratories Inc. has agreed to pay $35 million to settle antitrust claims with a class of people who bought its blockbuster acne drug Solodyn, bringing a portion of its four-year ... The Impax settlement is subject to approval by the court. ... The case is In re Solodyn Antitrust Litigation , D. Mass., No.


Oct 31, 2017 ... The case is In re Opana ER Antitrust Litigation, MDL No. 2580 (N.D. Ill.). Labaton Sucharow represents Massachusetts Bricklayers & Masons Health and Welfare Fund. The defendants are Endo Health Solutions, Inc., Endo Pharmaceuticals, Inc., Penwest Pharmaceuticals Co., and Impax Laboratories, Inc.


Mar 12, 2018 ... BOSTON, March 12- Impax Laboratories Inc went to trial on Monday over claims by major retailers and consumers that the company agreed to delay launching a generic version of ... The case is In re Solodyn (Minocycline Hydrochloride) Antitrust Litigation, U.S. District Court, District of Massachusetts, No.


Aug 7, 2017 ... HAYWARD, Calif., Aug. 7, 2017 /PRNewswire/ -- Impax Laboratories, Inc. ( NASDAQ: IPXL), today announced a Settlement Agreement (the "Contract Settlement Agreement") to resolve a contract dispute relating to an agreement entered into in June 2010 among Endo International plc ("Endo"), Penwest ...


(510) 240-6000. (Registrant's telephone number, including area code). Not Applicable. (Former name, former address and former fiscal year, if changed since last report). Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 ...


Apr 6, 2018 ... January 16, 2018. application/pdf icon Intervenor Endo Pharmaceuticals Inc.'s Opposition to Complaint Counsel's Findings and Proposed Relief Regarding the Endo-Impax 2017 Settlement Agreement (456.11 KB) ...